These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19533498)

  • 21. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population.
    Jiang S; Bao Y; Hou X; Fang Q; Wang C; Pan J; Zuo Y; Zhong W; Xiang K; Jia W
    Am J Cardiol; 2009 Jun; 103(12):1727-31. PubMed ID: 19539083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation and embolization in ischemic heart disease.
    Topol EJ
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():2B-7B. PubMed ID: 10731293
    [No Abstract]   [Full Text] [Related]  

  • 23. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein and dangerous liaisons.
    Biasucci LM
    Eur Heart J; 2000 Oct; 21(19):1560-2. PubMed ID: 10988002
    [No Abstract]   [Full Text] [Related]  

  • 25. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
    Bagheri N; Taziki O; Falaknazi K
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and high-sensitivity C-reactive protein in Cubans.
    Huffman FG; Gomez GP; Zarini GG
    Ethn Dis; 2009; 19(2):115-20. PubMed ID: 19537220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein and cerebral small-vessel disease: an opportunity to reassess small-vessel disease physiopathology?
    Di Napoli M; Papa F
    Circulation; 2005 Aug; 112(6):781-5. PubMed ID: 16087807
    [No Abstract]   [Full Text] [Related]  

  • 28. I have elevated levels of C-reactive protein. How does that affect my risk of developing heart disease?
    Gibbons E
    Health News; 2002 Nov; 8(11):12. PubMed ID: 12523257
    [No Abstract]   [Full Text] [Related]  

  • 29. C-reactive protein in ischaemic cardiomyopathy: assessing vascular risk in heart failure.
    Dickstein K
    Eur Heart J; 2005 Nov; 26(21):2218-9. PubMed ID: 16195321
    [No Abstract]   [Full Text] [Related]  

  • 30. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
    Vivona N; Bivona G; Noto D; Sasso BL; Cefalù AB; Chiarello G; Falletta A; Ciaccio M; Averna MR
    Clin Biochem; 2009 Nov; 42(16-17):1713-8. PubMed ID: 19732763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative C-reactive protein levels to predict early and late mortalities after coronary artery bypass surgery: eight years of follow-up.
    van Straten AH; Soliman Hamad MA; van Zundert AJ; Martens EJ; Schönberger JP; de Wolf AM
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):954-8. PubMed ID: 19660390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of atherosclerosis risk factors in development of ischemic heart disease in young men].
    Ezhov MV; Afanas'eva OI; Kambegova AA; Afanas'eva MI; Trukhacheva EP; Naumov VG; Pokrovskiĭ SN
    Ter Arkh; 2009; 81(5):50-4. PubMed ID: 19537587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholesterol reduction: ischemic heart disease and mortality from non-ischemic heart diseases].
    Hansen PS
    Ugeskr Laeger; 1994 Apr; 156(17):2608-9. PubMed ID: 8016976
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
    De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
    J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein to distinguish pneumonia from acute decompensated heart failure.
    Joffe E; Justo D; Mashav N; Swartzon M; Gur H; Berliner S; Paran Y
    Clin Biochem; 2009 Nov; 42(16-17):1628-34. PubMed ID: 19703436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should physicians measure high-sensitivity C-reactive protein levels to assess coronary heart disease risk?
    Alpert JS
    Am J Med; 2009 May; 122(5):405-6. PubMed ID: 19375543
    [No Abstract]   [Full Text] [Related]  

  • 39. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.
    Lu LF; Yang SS; Wang CP; Hung WC; Yu TH; Chiu CA; Chung FM; Shin SJ; Lee YJ
    J Stroke Cerebrovasc Dis; 2009; 18(5):354-9. PubMed ID: 19717018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
    van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ
    Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.